Skip to main content
Top
Published in: World Journal of Urology 6/2015

01-06-2015 | Original Article

Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study

Authors: F. Pedro J. Daels, Andrius Gaizauskas, Jorge Rioja, Anil K. Varshney, Erkan Erkan, Yasar Ozgok, Michael Melekos, Jean J. M. C. H. de la Rosette

Published in: World Journal of Urology | Issue 6/2015

Login to get access

Abstract

Purpose

This study examined the prevalence of risk factors for urological stone surgery and their possible influence on outcome and complications following ureteroscopy (URS).

Methods

The Clinical Research Office of the Endourological Society Ureteroscopy Global Study collected prospective data on consecutive patients with urinary stones treated with URS at centers around the world for 1 year. The prevalence of common comorbidities and anticoagulation therapy and their relationship with complications and age were examined.

Results

Of 11,719 patients, 2,989 patients (25.8 %) had cardiovascular disease, including 22.6 % with hypertension, and 1,266 patients (10.9 %) had diabetes mellitus. Approximately six percent of patients were receiving oral anticoagulation therapy, including aspirin (3.7 %) and clopidogrel (0.8 %). The prevalence of hypertension and diabetes mellitus and the proportion of patients receiving anticoagulant medication and/or antidiabetes treatment increased with age. Elderly were more likely to develop a postoperative complication when they had diabetes, a cardiovascular disease or received anticoagulation therapy. Post-operative bleeding was higher in patients receiving anticoagulants than those not receiving them (1.1 vs. 0.4 %; p < 0.01). Patients with risk factors for stone formation had more complications than those without (4.9 vs. 3.0 %, p < 0.001).

Conclusions

This is the first study confirming in a global population that URS can effectively and safely be performed in a population with high comorbidity. The risk of a complication was highest among elderly patients presenting with comorbidities.
Literature
1.
go back to reference Hesse A, Brändle E, Wilbert D et al (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 versus 2000. Eur Urol 44:709CrossRefPubMed Hesse A, Brändle E, Wilbert D et al (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 versus 2000. Eur Urol 44:709CrossRefPubMed
2.
go back to reference Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848CrossRefPubMed Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848CrossRefPubMed
3.
go back to reference Yasui T, Iguchi M, Suzuki S et al (2008) Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71:209CrossRefPubMed Yasui T, Iguchi M, Suzuki S et al (2008) Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71:209CrossRefPubMed
4.
7.
go back to reference De la Rosette J, Denstedt J, Geavlete P et al (2014) The Clinical Research Office of the Endourological Society Ureteroscopy Global Study: indications, complications, and outcomes in 11885 patients. J Endourol 28(2):131CrossRefPubMed De la Rosette J, Denstedt J, Geavlete P et al (2014) The Clinical Research Office of the Endourological Society Ureteroscopy Global Study: indications, complications, and outcomes in 11885 patients. J Endourol 28(2):131CrossRefPubMed
9.
go back to reference Wild S, Roglic G, Green A et al (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047CrossRefPubMed Wild S, Roglic G, Green A et al (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047CrossRefPubMed
10.
go back to reference Kearney PM, Whelton M, Reynolds K et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217CrossRefPubMed Kearney PM, Whelton M, Reynolds K et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217CrossRefPubMed
11.
go back to reference De la Rosette J, Assimos D, Desai M et al (2011) The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol 25:11CrossRefPubMed De la Rosette J, Assimos D, Desai M et al (2011) The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol 25:11CrossRefPubMed
12.
go back to reference Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9(12 Suppl):S16PubMed Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9(12 Suppl):S16PubMed
13.
go back to reference National Kidney Foundation (2013) Kidney Early Evaluation Program (KEEP) 2012 summary figures. Am J Kidney Dis 61(suppl 2):S33 National Kidney Foundation (2013) Kidney Early Evaluation Program (KEEP) 2012 summary figures. Am J Kidney Dis 61(suppl 2):S33
14.
go back to reference Bagga HS, Chi T, Miller J et al (2013) New insights into the pathogenesis of renal calculi. Urol Clin N Am 40:1CrossRef Bagga HS, Chi T, Miller J et al (2013) New insights into the pathogenesis of renal calculi. Urol Clin N Am 40:1CrossRef
15.
go back to reference Ball J, Carrington MJ, McMurray JJ et al (2013) Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 167:1807CrossRefPubMed Ball J, Carrington MJ, McMurray JJ et al (2013) Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 167:1807CrossRefPubMed
16.
go back to reference Ogilvie IM, Newton N, Welner SA et al (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123:638CrossRefPubMed Ogilvie IM, Newton N, Welner SA et al (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123:638CrossRefPubMed
17.
go back to reference Skolarikos AA, Papatsoris AG, Mitsogiannis IC et al (2009) Current status of ureteroscopic treatment for urolithiasis. Int J Urol 16:713CrossRefPubMed Skolarikos AA, Papatsoris AG, Mitsogiannis IC et al (2009) Current status of ureteroscopic treatment for urolithiasis. Int J Urol 16:713CrossRefPubMed
18.
go back to reference Nerli RB, Reddy MN, Devaraju S et al (2012) Percutaneous nephrolithotomy in patients on chronic anticoagulant/antiplatelet therapy. Chonnam Med J 48:103CrossRefPubMedCentralPubMed Nerli RB, Reddy MN, Devaraju S et al (2012) Percutaneous nephrolithotomy in patients on chronic anticoagulant/antiplatelet therapy. Chonnam Med J 48:103CrossRefPubMedCentralPubMed
19.
go back to reference Lange JN, Mufarrij PW, Passman CM et al (2013) Safety and efficacy of removable inferior vena cava filters in anticoagulated patients undergoing percutaneous nephrostolithotomy. J Endourol 27:168CrossRefPubMed Lange JN, Mufarrij PW, Passman CM et al (2013) Safety and efficacy of removable inferior vena cava filters in anticoagulated patients undergoing percutaneous nephrostolithotomy. J Endourol 27:168CrossRefPubMed
20.
go back to reference Turna B, Stein RJ, Smaldone MC et al (2008) Safety and efficacy of flexible ureterorenoscopy and holmium: YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol 179:1415CrossRefPubMed Turna B, Stein RJ, Smaldone MC et al (2008) Safety and efficacy of flexible ureterorenoscopy and holmium: YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol 179:1415CrossRefPubMed
Metadata
Title
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study
Authors
F. Pedro J. Daels
Andrius Gaizauskas
Jorge Rioja
Anil K. Varshney
Erkan Erkan
Yasar Ozgok
Michael Melekos
Jean J. M. C. H. de la Rosette
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 6/2015
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-014-1382-6

Other articles of this Issue 6/2015

World Journal of Urology 6/2015 Go to the issue